Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblastsZhite Zhao, Changhong Shi, Yifan Ma et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 13
Supramolecular lipid nanoparticle reprograms tumor microenvironment by cucurbit[7]uril-based host–guest recognition for STING-activating cancer immunotherapyYunxuan Feng, Guocan Yu, Yu Yuan et al.|Materials Today|2025Cited by 2